7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow VIVUS LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects VI-0521, Phentermine, Placebo - Blood Pressure | Phase 4 | Completed | VIVUS LLC | 565 | 2022-01-25 | 2024-07-17 |
| A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity VI-0521 oral capsule, Placebo oral capsule, Lifestyle Modification - Adolescent Obesity, Obesity in Adolescence | Phase 4 | Completed | VIVUS LLC | 223 | 2019-05-02 | 2022-09-10 |
| A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents Placebo, VI-0521 Mid Dose, VI-0521 Top Dose - Pediatric Obesity, Childhood Obesity | Phase 4 | Completed | VIVUS LLC | 42 | 2016-03-01 | 2022-08-23 |
| Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects Qsymia, Placebo - Obesity | Phase 4 | Completed | VIVUS LLC | 51 | 2014-08-01 | 2017-11-07 |
| Safety Study Looking at the Effects of Stendra on Vision Stendra 200 mg, Placebo - Vision | Phase 4 | Completed | VIVUS LLC | 80 | 2014-01-01 | 2015-03-13 |
| Study Evaluating the Effects of Avanafil on Semen Parameters avanafil, Placebo - Erectile Dysfunction | Phase 4 | Completed | VIVUS LLC | 181 | 2012-12-01 | 2015-12-14 |
| Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Placebo, Avanafil 100 mg, Avanafil 200 mg - Erectile Dysfunction | Phase 4 | Completed | VIVUS LLC | 440 | 2012-09-01 | 2014-10-27 |
Obesity (3) · Erectile Dysfunction (2) · Pediatric Obesity (2) · Overweight (1) · Weight Loss (1)
Qsymia (4) · avanafil (3) · Phentermine (2) · Sugars (2)
United States (7)
Chris Galloway, MD (1) · Chuck Bowden, M.D. (1) · Daniel Hsia, M.D. (1)